Theranostics in Hematooncology-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Theranostics in Hematooncology

Published:2023-06-08 Issue:7 Volume:64 Page:1009-1016
ISSN:0161-5505
Container-title:Journal of Nuclear Medicine
language:en
Short-container-title:J Nucl Med

Author:

Buck Andreas K.,Serfling Sebastian E.,Kraus Sabrina,Samnick Samuel,Dreher Niklas,Higuchi Takahiro,Rasche Leo,Einsele Hermann,Werner Rudolf A.

Publisher

Society of Nuclear Medicine

Subject

Radiology, Nuclear Medicine and imaging

Reference67 articles.

1. Lutetium-177–PSMA-617 for Metastatic Castration-Resistant Prostate Cancer

2. [177Lu]Lu-PSMA-617 versus cabazitaxel in patients with metastatic castration-resistant prostate cancer (TheraP): a randomised, open-label, phase 2 trial;Hofman;Lancet.,2021

3. 177Lu-Dotatate plus long-acting octreotide versus high-dose long-acting octreotide in patients with midgut neuroendocrine tumours (NETTER-1): final overall survival and long-term safety results from an open-label, randomised, controlled, phase 3 trial;Strosberg;Lancet Oncol.,2021

4. Phase 3 Trial of 177Lu-Dotatate for Midgut Neuroendocrine Tumors

5. 131I-Tositumomab Therapy as Initial Treatment for Follicular Lymphoma

Cited by 11 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Radioligand Therapy in Lymphoma;PET Clinics;2024-10

2. Predictive value of C-X-C motif chemokine receptor 4-directed molecular imaging in patients with advanced adrenocortical carcinoma;European Journal of Nuclear Medicine and Molecular Imaging;2024-06-19

3. Baseline Tumor Burden is Associated with Bone Marrow Involvement in Low-grade;2024-05-02

4. 68Ga-Pentixafor PET/CT for In Vivo Imaging of CXCR4 Receptors in Glioma Demonstrating a Potential for Response Assessment to Radiochemotherapy: Preliminary Results;Clinical Nuclear Medicine;2024-02-01

5. Alpha-Emitting Radionuclides: Current Status and Future Perspectives;Pharmaceuticals;2024-01-08

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3